Prevalence of Fibrosis and Applicability of Lab-Based Noninvasive Tests From Primary to Tertiary CareGeorg Semmler, Elmar Aigner, Paul Thöne et al.|Clinical Gastroenterology and Hepatology|2025Cited by 10
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLDMathias Jachs, Sven Francque, Paul Thöne et al.|Journal of Hepatology|2025Cited by 5
Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute DecompensationLucie Simonis, Georg Semmler, Lorenz Balcar et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 5
<scp>GDF</scp> ‐15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical OutcomesBenedikt Hofer, Thomas Gremmel, Christian Sebesta et al.|Liver International|2026Cited by 3
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and DeathMathias Jachs, Mattias Mandorfer, Tânia Carvalho et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 3